SA
RVMD logo
Revolution Medicines, Inc.(RVMD)
Closing price · checked 8:38 PM ETAbout this dataData status
$161.20▲1.77 (1.11%)
Extended:$165.50+4.30 (+2.67%)· 8:38 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Revolution Medicines, Inc. (RVMD)

Total Non-Current Liabilities

$1.43B

Quarterly · Period ending: · USD

RVMD logo

RVMD Total Non-Current Liabilities

Latest reported$432.79M
RVMD FY Total Non-Current Liabilities ($2.95M → $432.79M)
Powered by
High-resolution chart · PNG

What is total non-current liabilities?

Long-term obligations due beyond one year.

RVMD total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Revolution Medicines, Inc. Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)Change
432,787,000+235.02%
129,183,000+40.94%
91,660,000+41.54%
64,758,000−13.74%
75,070,000+64.81%
45,549,000+82.62%
24,942,000−42.50%
43,375,000+1,371.34%
2,948,000—

Frequently asked questions: RVMD total non-current liabilities

What is Revolution Medicines, Inc. (RVMD)'s current total non-current liabilities?

Revolution Medicines, Inc. (RVMD)'s latest reported total non-current liabilities (Quarterly) is $1.43B as of Sep 30, 2026. Long-term obligations due beyond one year.

How much historical total non-current liabilities data is available for RVMD?

Stock Alarm Pro provides 9 dated annual fiscal periods observations for Revolution Medicines, Inc. (RVMD)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare RVMD's total non-current liabilities to peers or set an alert?

You can open RVMD's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RVMD delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.